Immuron Ltd (IMRN) income statement
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.87−0.00 (-0.52%)
Close on Nov 18, 2026Market cap $6.99MP/E –Yield –
Immuron Ltd income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2026
- Gross margin
- 64.5%
- Operating margin
- -49.9%
- Net margin
- -47.7%
- Return on equity, FY2026
- –
Financial strength
- Current ratio
- 7.26
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 505.1%
Valuation
- P/E ratio
- –
- Price to sales
- 1.34
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?